First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance
| Image |  |
|---|---|
| Description | scientific article published on 4 April 2018 |
| Author/s |
author: Wenfeng Fang |
| Publication date | April 4, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |